SB

Sumant Balkrishna Khanolkar

Director Director DIN 00322723
DIN 00322723 First appointment Jan 2001 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2001
Shareholding value •••• Premium profile

About Sumant Balkrishna Khanolkar

Data last updated:

Sumant Balkrishna Khanolkar was a Director at Oxford Laboratories Private Limited (2001–2017) and Director at Oxford Lifesciences Private Limited (2003–2017). The companies operate in Pharma and Healthcare.

DIN 00322723
Primary Designation Director
Industry Pharma
First Appointment 27 Jan 2001

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Oxford Laboratories Private Limited U24230MH2000PTC123927
Director27 Jan 20012000₹67.77 Cr (FY 2025)Active
Oxford Lifesciences Private Limited U24230MH2003PTC139562
Director12 Mar 20032003₹2.11 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Oxford Laboratories Private Limited
Oxford Lifesciences Private Limited
Premium access

Shareholding and investment profile for Sumant Balkrishna Khanolkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sumant Balkrishna Khanolkar

Sumant Balkrishna Khanolkar was first appointed on 27 Jan 2001 as Director at Oxford Laboratories Private Limited. The most recent appointment on record is 12 Mar 2003 at Oxford Lifesciences Private Limited.

Sumant Balkrishna Khanolkar held 2 earlier board appointments: Oxford Laboratories Private Limited (Director, 27 Jan 2001 to 03 May 2017); Oxford Lifesciences Private Limited (Director, 12 Mar 2003 to 03 May 2017).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available